Baloxavir Manufacturer

Tina30 Jun, 2022Business

Baloxavir is currently approved by the FDA for the treatment of acute uncomplicated influenza within 2 days of the onset of influenza in people 12 years of age and older who are in good health or at increased risk for influenza-related complications, and for post-influenza exposure prophylaxis in people 12 years of age and older.